SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

14 Nov 2025 Evaluate
The turnover is pegged at Rs. 8916.13 millions for the September 2025 quarter. The mentioned figure indicates a rise of about 56.98% as against Rs. 5679.91 millions during the year-ago period.The Net Profit of the company vaulted to 191.39% to Rs. 1206.13  millions from Rs. 413.92 millions in the previous quarter.Operating Profit saw a handsome growth to 2193.00 millions from 1053.83 millions in the quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 8916.13 5679.91 56.98 17018.21 14199.41 19.85 30301.63 37550.91 -19.31
Other Income 78.85 27.80 183.63 210.37 45.88 358.52 406.80 57.77 604.17
PBIDT 2193.00 1053.83 108.10 3760.87 2846.06 32.14 6054.84 8071.37 -24.98
Interest 166.53 145.62 14.36 303.26 320.79 -5.46 627.80 719.98 -12.80
PBDT 2026.47 908.21 123.13 3336.01 2525.27 32.11 5734.54 7351.39 -21.99
Depreciation 407.41 347.47 17.25 802.48 705.94 13.68 1462.30 1438.48 1.66
PBT 1619.06 560.74 188.74 2533.53 1819.33 39.26 4272.24 5912.91 -27.75
TAX 412.93 146.82 181.25 632.55 467.62 35.27 1078.88 1553.73 -30.56
Deferred Tax -18.25 14.84 -222.98 -28.55 25.37 -212.53 -19.91 47.68 -141.76
PAT 1206.13 413.92 191.39 1900.98 1351.71 40.64 3193.36 4359.18 -26.74
Equity 242.67 242.37 0.12 242.67 242.37 0.12 242.54 242.37 0.07
PBIDTM(%) 24.60 18.55 32.57 22.10 20.04 10.26 19.98 21.49 -7.04

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×